CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,690,690 | -32.3% | 754,725 | -30.3% | 0.04% | -31.7% |
| Q1 2024 | $17,263,610 | +63.2% | 1,083,037 | +72.1% | 0.06% | +50.0% |
| Q4 2023 | $10,579,743 | +126.2% | 629,372 | +57.3% | 0.04% | +82.6% |
| Q3 2023 | $4,677,859 | +60.9% | 400,159 | +85.0% | 0.02% | +64.3% |
| Q2 2023 | $2,907,596 | -65.1% | 216,339 | -57.0% | 0.01% | -65.9% |
| Q1 2023 | $8,338,546 | -11.5% | 502,928 | -0.7% | 0.04% | -21.2% |
| Q4 2022 | $9,420,826 | +2.4% | 506,496 | -29.3% | 0.05% | +4.0% |
| Q3 2022 | $9,196,000 | +1765.3% | 716,746 | +459.8% | 0.05% | +257.1% |
| Q1 2020 | $493,000 | -53.8% | 128,039 | -55.0% | 0.01% | -33.3% |
| Q4 2019 | $1,067,000 | +1047.3% | 284,598 | +1526.6% | 0.02% | +950.0% |
| Q3 2019 | $93,000 | – | 17,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
| TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
| GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
| MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
| Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
| Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
| Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
| KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
| EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
| CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |